BackgroundThe rapid spread of HBV has resulted in the emergence of new variants. These viral genotypes and variants, in addition to carcinogenic risk, can be key predictors of therapy response and out
Wa (G1P[8]), DS-1 (G2P[4]), and AU-1(G3P[9]) strains were used as references for genotype 1 (Wa-like), genotype 2 (DS-1 like), and genotype 3 (AU-1 like), respectively.
Background: The epidemic NAP1/027 Clostridioides difficile strain (MLST1, ST1) that emerged in the mid-2000 is on the decline. The current distribution of C. difficile strain types and their transmiss
Burkholderia pseudomallei, as a saprophytic bacterium that can cause a severe sepsis disease named melioidosis, has preserved several extra genes in its genome for survival. The sequenced genome of th
